Dalman, Teodora A.
HRN: 09-58-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
02/16/2023
02/26/2023
IV
750
Every Other Day
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes